About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Current Treatment Options in Rheumatology
›
top-articles
Current Treatment Options in Rheumatology
0.9
(top 50%)
impact factor
190
(top 50%)
papers
1.1K
(top 50%)
citations
18
(top 50%)
h
-index
0.9
(top 50%)
impact factor
209
all documents
1.2K
doc citations
27
(top 50%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Management of Gastrointestinal Involvement in Scleroderma
Current Treatment Options in Rheumatology
2015
64
2
Hand Impairment in Systemic Sclerosis: Various Manifestations and Currently Available Treatment
Current Treatment Options in Rheumatology
2016
53
3
Neurological Complications of Sjögren’s Syndrome: Diagnosis and Management
Current Treatment Options in Rheumatology
2017
45
4
Giant Cell Arteritis: From Pathogenesis to Therapeutic Management
Current Treatment Options in Rheumatology
2016
42
5
Pharmacologic and Non-Pharmacologic Treatment of Osteoarthritis
Current Treatment Options in Rheumatology
2016
40
6
Current Treatment for Myositis
Current Treatment Options in Rheumatology
2018
36
7
Rheumatoid Arthritis–Associated Interstitial Lung Disease: Current Update on Prevalence, Risk Factors, and Pharmacologic Treatment
Current Treatment Options in Rheumatology
2020
35
8
What Does the COVID-19 Pandemic Mean for Rheumatology Patients?
Current Treatment Options in Rheumatology
2020
35
9
Weathering the Storm: Improving Therapeutic Interventions for Cytokine Storm Syndromes by Targeting Disease Pathogenesis
Current Treatment Options in Rheumatology
2017
33
10
Osteoporosis Management in Ankylosing Spondylitis
Current Treatment Options in Rheumatology
2016
31
11
An Update on Treatment of Pediatric Chronic Non-infectious Uveitis
Current Treatment Options in Rheumatology
2017
31
12
An Update on the Treatment of Pediatric Autoimmune Encephalitis
Current Treatment Options in Rheumatology
2018
31
13
Avoidance of Harm From Treatment for ANCA-Associated Vasculitis
Current Treatment Options in Rheumatology
2017
30
14
The Risk Benefit Ratio of Glucocorticoids in SLE: Have Things Changed over the Past 40 years?
Current Treatment Options in Rheumatology
2017
29
15
Exercise in Myositis
Current Treatment Options in Rheumatology
2018
23
16
Myositis-Related Interstitial Lung Diseases: Diagnostic Features, Treatment, and Complications
Current Treatment Options in Rheumatology
2019
23
17
Scleroderma Mimickers
Current Treatment Options in Rheumatology
2016
21
18
Current Evidence-Based Interdisciplinary Treatment Options for Pediatric Musculoskeletal Pain
Current Treatment Options in Rheumatology
2018
20
19
Juvenile Dermatomyositis: New Clues to Diagnosis and Therapy
Current Treatment Options in Rheumatology
2021
20
20
Pharmacologic Treatment of Anti-MDA5 Rapidly Progressive Interstitial Lung Disease
Current Treatment Options in Rheumatology
2021
17
21
Rituximab: the Lupus Journey
Current Treatment Options in Rheumatology
2015
16
22
Autoantibodies and Their Role in Scleroderma Clinical Care
Current Treatment Options in Rheumatology
2016
16
23
Gout and Hyperuricemia: an Historical Perspective
Current Treatment Options in Rheumatology
2015
15
24
Addressing Mental Health in Pediatric Rheumatology
Current Treatment Options in Rheumatology
2018
14
25
The Role of Vascular Imaging to Advance Clinical Care and Research in Large-Vessel Vasculitis
Current Treatment Options in Rheumatology
2019
14
26
An Update on Treatment of Kawasaki Disease
Current Treatment Options in Rheumatology
2019
14
27
Management of Widespread Pain and Fibromyalgia
Current Treatment Options in Rheumatology
2016
13
28
Management of Calcinosis Associated with Systemic Sclerosis
Current Treatment Options in Rheumatology
2016
12
29
The Role of Patient-Reported Outcomes in Systemic Lupus Erythematosus
Current Treatment Options in Rheumatology
2017
12
30
Pharmacotherapy Options in the Management of Raynaud’s Phenomenon
Current Treatment Options in Rheumatology
2018
12
31
Lymphoma in Sjögren’s Syndrome: Predictors and Therapeutic Options
Current Treatment Options in Rheumatology
2020
12
32
Efficacy and Safety of Platelet-Rich Plasma Injections for Osteoarthritis
Current Treatment Options in Rheumatology
2020
12
33
The Importance of Hip Shape in Predicting Hip Osteoarthritis
Current Treatment Options in Rheumatology
2018
11
34
Evaluation and Treatment of Childhood Enthesitis-Related Arthritis
Current Treatment Options in Rheumatology
2015
10
35
Measuring Disease Progression in Osteoarthritis
Current Treatment Options in Rheumatology
2016
10
36
Knee and Hip Osteoarthritis Management: A Review of Current and Emerging Non-Pharmacological Approaches
Current Treatment Options in Rheumatology
2016
10
37
Management of Renal Involvement in Scleroderma
Current Treatment Options in Rheumatology
2015
9
38
Self-Efficacy and the Role of Non-pharmacologic Treatment Strategies to Improve Pain and Affect in Arthritis
Current Treatment Options in Rheumatology
2019
9
39
Challenges and Advances in SLE Autoantibody Detection and Interpretation
Current Treatment Options in Rheumatology
2019
9
40
Therapeutic Management of Immune-Mediated Necrotizing Myositis
Current Treatment Options in Rheumatology
2021
9
41
Dysregulation of Type I Interferon Signaling in Systemic Sclerosis: a Promising Therapeutic Target?
Current Treatment Options in Rheumatology
2021
9
42
TNF and IL-1 Targeted Treatment in Kawasaki Disease
Current Treatment Options in Rheumatology
2016
8
43
Management of Musculoskeletal Involvement in Systemic Sclerosis
Current Treatment Options in Rheumatology
2016
8
44
Cutaneous Lupus Erythematosus: Current Treatment Options
Current Treatment Options in Rheumatology
2016
8
45
Treatment Advances in Chronic Non-Bacterial Osteomyelitis and Other Autoinflammatory Bone Conditions
Current Treatment Options in Rheumatology
2017
8
46
Novel Therapeutic Targets in Axial Spondyloarthritis
Current Treatment Options in Rheumatology
2018
8
47
Insight into the Contrasting Findings of Therapeutic Trials of Digital Ischaemic Manifestations of Systemic Sclerosis
Current Treatment Options in Rheumatology
2019
8
48
An Update on Targets for Treating Osteoarthritis Pain: NGF and TRPV1
Current Treatment Options in Rheumatology
2020
8
49
Outcome Measures for Gout Clinical Trials: a Summary of Progress
Current Treatment Options in Rheumatology
2015
7
50
Clinical Trials in Vasculitis
Current Treatment Options in Rheumatology
2016
7
site/software ©
exaly
; All materials licenced under
CC by-SA
.